DERMAGO sell "VEREGEN®"

An innovative originator herbal product based on sinecatechins, an extract from green tea leaves, indicated for external anogenital warts caused by human papillomavirus types 6 and 11, formulated as an ointment. Global in-market sales reached about EUR 11 million (roughly 105,000 units) in 2020, with patent protection through 2029 and a unique, complex API manufacturing process providing further long-term protection; its broad mechanism of action also supports development in additional indications.